HARVARD BIOSCIENCE, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2020-03-31 was 0.00 shares.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2019-12-31 was 96.64K shares, a 50.28% increase year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2019-09-30 was -93.69M shares.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2019-06-30 was 94.00K shares, a 276.00% increase year-over-year.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 200.00K shares, a 100.00% increase from fiscal 2021.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2021 was 100.00K shares, a 20.80% decline from fiscal 2020.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2020 was 126.25K shares, a 33.77% decline from fiscal 2019.
- HARVARD BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2019 was 190.64K shares, a 113.47% increase from fiscal 2018.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2022-12-31 | 200.00K shares 10-K · filed 2023-03-09 | |
| 2021-12-31 | 100.00K shares 10-K · filed 2023-03-09 | |
| 2020-12-31 | 126.25K shares 10-K · filed 2022-03-11 | |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-08 | -93.50M shares derived: sum of 4 quarters · filed 2021-03-17 |
| 2019-12-31 | 96.64K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | 190.64K shares 10-K/A · filed 2021-03-17 |
| 2019-09-30 | -93.69M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -93.53M shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-06-30 | 94.00K shares 10-Q · filed 2019-08-08 | 158.31K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-08 | 89.31K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | 64.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 89.31K shares 10-K · filed 2020-03-16 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-11-08 | 863.07K shares derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | 25.00K shares 10-Q · filed 2019-08-08 | 899.97K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | 801.45K shares 10-Q · filed 2018-05-10 | 911.87K shares derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-12-31 | 36.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 76.22K shares 10-K · filed 2019-03-18 |
| 2017-09-30 | 36.90K shares 10-Q · filed 2017-11-02 | -528.33K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | 36.90K shares 10-Q · filed 2017-08-03 | -525.88K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-10 | -523.43K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | -602.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 81.23K shares 10-K · filed 2018-03-16 |
| 2016-09-30 | 39.35K shares 10-Q · filed 2017-11-02 | |
| 2016-06-30 | 39.35K shares 10-Q · filed 2017-08-03 | |
| 2015-12-31 | 32.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 58.82K shares 10-K · filed 2018-03-16 |
| 2015-09-30 | 26.18K shares 10-Q · filed 2016-11-03 | 79.09K shares derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-06-30 | 26.18K shares 10-Q · filed 2016-08-04 | 84.03K shares derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-03-31 | 0.00 shares derived: 10-Q 183 month − 10-K 180 month · filed 2015-05-07 | 88.96K shares derived: sum of 4 quarters · filed 2017-03-17 |
| 2014-12-31 | 26.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | 57.85K shares 10-K · filed 2017-03-17 |
| 2014-09-30 | 31.12K shares 10-Q · filed 2014-11-06 | |
| 2014-06-30 | 31.12K shares 10-Q · filed 2015-08-06 | |
| 2013-12-31 | 29.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | 56.94K shares 10-K · filed 2016-04-29 |
| 2013-09-30 | 27.30K shares 10-Q · filed 2014-11-06 | 89.04K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | 27.30K shares 10-Q · filed 2014-08-07 | 61.74K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | 60.03K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | 34.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | 60.03K shares 10-K · filed 2015-03-12 |
| 2012-09-30 | 0.00 shares 10-Q · filed 2013-11-08 | 52.01K shares derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | 25.60K shares 10-Q · filed 2013-08-09 | 52.01K shares derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | 26.41K shares derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | 26.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | 49.00K shares 10-K · filed 2014-03-14 |
| 2011-09-30 | 0.00 shares 10-Q · filed 2012-11-08 | |
| 2011-06-30 | 0.00 shares 10-Q · filed 2012-08-09 | |
| 2010-12-31 | 52.00K shares 10-K · filed 2013-03-18 | |
| 2009-12-31 | 38.00K shares 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |